Re: Covid-19: Arthritis drug tocilizumab reduces deaths in hospitalised patients, study shows
(Source: BMJ Comments)
Source: BMJ Comments - February 23, 2021 Category: General Medicine Source Type: forums
Tocilizumab for COVID-19: Difficulties in Interpreting the Results of RCTs vs. Observational Studies
(Source: BMJ Comments)
Source: BMJ Comments - February 8, 2021 Category: General Medicine Source Type: forums
Escalating anti-inflammatory therapy with tocilizumab in patients with severe COVID-19
(Source: BMJ Comments)
Source: BMJ Comments - January 24, 2021 Category: General Medicine Source Type: forums
Treating COVID pre and post intubation
Anecdotally it seems like we have two categories of treatments.
1. Hydroxychloroquine +/- azithromycin.
2. Xeljanz/Anakinra/Tocilizumab.
The first category is treating the virus and superimposed bacteria. The second category is treating the cytokine storm and quite useful for when the patient is in ARDS. I think it's a reasonable school of thought that the first category should be used early (outpatients and early inpatient) and the second category should be the primary treatment modality...
Treating COVID pre and post intubation (Source: Student Doctor Network)
Source: Student Doctor Network - March 22, 2020 Category: Universities & Medical Training Authors: MedicineZ0Z Tags: Critical Care Source Type: forums
